Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-30

FDA Approved: GLYBURIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for glyburide from Teva Pharmaceuticals USA, Inc., confirming approval of this generic product. The action pertains …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glyburide (glyburide)

Snippet

SUPPL AP for GLYBURIDE (GLYBURIDE)